• Invest
    Investment Suite
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Currency
    Non Convertible Debentures
    Sovereign Gold Bond
    Exclusive
    NRI Account
    Private Client Group
    Features
    SipIt
    MTF
    Investment Suite
    Exclusive
    Features
  • Platform
    Product Suite
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Features and Tools
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Equity Screeners
    Payoff Analyzer
    Calculators
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    SWP Calculator
    CAGR Calculator
    Simple Interest Calculator
    ELSS Calculator
    Step up SIP Calculator
    All Calculators
    Product Suite
    Features and Tools
    Calculators
  • Pricing
  • Research
    Research Calls
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Research Reports
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
    Research Calls
    Research Reports
  • Market
    Stocks
    Market Movers
    Large Cap
    Mid Cap
    Small Cap
    Indices
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    All Indian Indices
    Mutual Funds
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    All AMC's
    IPO
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Stocks
    Indices
    Mutual Funds
    IPO
  • Learn
    Resource
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Quarterly Results
    Investing Guide
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Commodities
    Currency
    Futures & Options
    Derivatives
    Margin Trading
    Events
    Budget 2024
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2025
    Resource
    Investing Guide
    Events
  • Partner
    Business Associates
    Fund Expert
    Kotak Connect Plus
    Startup connect
  • Support
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement

What is Dead Hand Provision?

  •  5 min read
  • 0
  • 06 Dec 2023
What is Dead Hand Provision?

Key Highlights

  • A dead-hand provision is a strategy for blocking takeovers by giving new shares to everyone except the hostile bidder who wants to buy the company.
  • The value of shares that the acquirer already owns is diluted, and its percentage of ownership is reduced, making it more expensive to take over.
  • Management cannot prohibit dead hand provisions because they can only be revoked by the approved board.

A dead-hand provision is a method businesses employ to respond to another that has started acquiring the former in a hostile manner. A dead hand provision and a requirement for new shares to be issued on the market is also a deadly poison pill. When a company knows that an unwanted acquirer has acquired enough of its shares from the secondary market, it issues new shares in a high volume, which dilutes the shares acquired by the unwanted acquirer. As a result of dilution, its holding in the unwanted acquirer will decrease below the specified amount so that it cannot obtain the company.

A dead-hand provision would make a takeover bid prohibitively expensive for the interested parties. This prevents potential acquirers from submitting an offer directly to shareholders or a newly elected board of directors. This would require the shareholders to retain their current management since it is they who can regain a poison pill.

Using the hostile takeover procedure, a company called XYZ is trying to acquire a company called PQR. It's buying 1,00,000 shares at the current price of Rs. 500, which is 10% of the company. PQR has no intention of having XYZ acquire it but cannot prohibit its secondary market shares from being acquired. Therefore, it knew that XYZ had a 10% holding in the company and could exercise its voting rights and have an effect on the board's decisions.

PQR issues 1,000,000 new shares, bringing the company's total outstanding shares to 1,000,000 in an attempt to prevent a hostile acquisition. This is done by using the dead-hand provision approach. As the supply increases and demand remains the same, the share price falls. Now, if XYZ wants to get back to 10%, it's going to have to buy another 1,00,000 shares, which is going to be expensive. The hostile takeover plan fails, allowing PQR to avoid the hostile takeover because XYZ will not spend more to maintain the same ownership.

Most firms with poison pills tend to avoid hostile takeover bids, helping them maintain their independence. Below are some of the effects of Dead Hand Poison pills on enterprises.

1. Use as bargaining instruments

The dead hand poison pill is occasionally used to negotiate to obtain the best conditions from bidders. The management's negotiating position is strengthened, and freshly elected directors cannot override them, mainly due to the inclusion of a pill that grants the current directors the ability to redeem it. The shareholders could elect a new board of directors, approving any deal that increases the shareholder value, if no poison pill were available. In a business environment where opportunistic acquirers initiate hostile takeover bids against failing or undercapitalised companies, management may also use dead hands to manage the company's future.

2. The shareholders' approval before the poison pill can be activated

In most cases, directors abuse the poison pill by using it in order to extend their terms even when a majority of shareholders do not like them. The provision constitutes coercion because it requires shareholders to keep the existing board members despite their wishes that a new board be set up that would have all its statutory powers and act in the best interest of those shareholders.

Activist shareholders are attempting to prevent this abuse of power by submitting proposals requiring shareholder approval before the board is able to put a new poison pill into the company's charter. This proposal would ensure that the company remains independent and avoid a decline in productivity and inefficiencies caused by poor management if implemented.

Conclusion

The provision of dead hands, which ensures that an unwanted entity does not acquire a company, is considered to be the crown jewel of the business world. It guarantees that the acquisition is carried out in accordance with ideal and agreed-upon terms, giving maximum control to the company. In addition, shareholders are protected from the Board of Directors, which may abuse its powers for their benefit. In essence, the dead-hand provision is a controversial and ideal business strategy that enables companies to remain in control under worst-case scenarios.

FAQs on Dead Hand Provision

The poison pills are conditions that companies include in the listing of their securities that prevent an individual from acquiring a majority interest. They usually have a share ownership threshold that can trigger the issue of additional shares to shareholders at discounts or for free.

A poison pill is a defensive technique used by the target company to prevent or discourage an acquiring undertaking from taking risks related to hostile takeovers. Prospective targets employ this approach to diminish their attraction to the possible acquirer.

This is the only substantial obligation of the purchaser to make a takeover offer. According to paragraph 26c of the Code, the target company cannot issue any securities conferring voting rights to the holder, thus eliminating any "poison pill" strategy.

Yes, when investors acquire new shares at a discount, they can profit immediately through poison pill strategies. The poison pill has the effect of diluting stock values, meaning that if a shareholder wishes to maintain an equal ownership interest in his company, then will need to acquire more shares.

A poison pill may be very effective in dissuading an acquisition, but it is seldom the only line of defence. This is because the strategy cannot be fully guaranteed to succeed since poison pills are not necessarily unable to stop a company from being acquired when an acquirer persists.

Did you enjoy this article?

0 people liked this article.

What could we have done to make this article better?

Enjoy Free Demat Account Opening
+91 -

personImage
Enjoy Free Demat Account Opening
+91 -

N
N
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]